Sphingosine-1-phosphate suppresses chondrosarcoma metastasis by upregulation of tissue inhibitor of metalloproteinase 3 through suppressing miR-101 expression

ASIAIR > College of Medical and Health Science > Department of Biotechnology > Journal Article > Item 310904400/108158

Please use this identifier to cite or link to this item: http://asiair.asia.edu.tw/ir/handle/310904400/108158

Title:	Sphingosine-1-phosphate suppresses chondrosarcoma metastasis by upregulation of tissue inhibitor of metalloproteinase 3 through suppressing miR-101 expression
Authors:	蔡俊灝;Chun-Hao Tsai;Dong-Ying Ya;Dong-Ying Yang;Chih-Yang Li;Chih-Yang Lin;Tsung-Ming C;Tsung-Ming Chen;湯智昕;Chih-Hsin Tang;黃元勵;HUANG, YUAN-LI
Contributors:	生物科技學系
Date:	2017-10
Issue Date:	2017-10-30 02:42:07 (UTC+0)
Abstract:	Chondrosarcoma is the second most common primary malignancy form of bone cancer, exhibiting resistance to chemotherapy and radiation therapy as well as developing high metastasis ability in late‐stage tumors. Thus, understanding the metastatic processes of chondrosarcoma is considered a strategy for the treatment of this disease. Sphingosine 1‐phosphate (S1P), a bioactive sphingolipid, is produced intracellularly by sphingosine kinase (SphK) and is regarded as a second signaling molecule that regulates inflammation, proliferation, angiogenesis, and metastasis. However, the effect of S1P on chondrosarcoma remains uncertain. As demonstrated by the transwell, immunoblotting, and real‐time PCR analyses, we found that S1P inhibited cell migration and MMP‐2 expression through the upregulation of the tissue inhibitor of metalloproteinase‐3 (TIMP‐3) expression in human chondrosarcoma cells. Additionally, we also showed that microRNA (miRNA)‐101, which targets the 3′ untranslated region (3′UTR) of TIMP‐3, decreased significantly following S1P treatment. After transfection with miR‐101 mimics, the S1P‐regulated cell migration and TIMP‐3 expression were both reversed. Furthermore, we also showed that the S1P‐inhibited cell migration is mediated through the c‐Src/MEK/ERK signaling axis. Meanwhile, the in vivo study indicated that overexpression of SphK1 decreases chondrosarcoma metastasis to the lungs. Our results illustrate the clinical significance between SphK1, TIMP‐3, and miR‐101 in human chondrosarcoma patients. Taken together, our results suggest that S1P and miR‐101 may prove to be potential therapeutic targets for future chondrosarcoma treatment. Keywords: chondrosarcoma, metastasis, microRNA, sphingosine‐1‐phosphate, tissue inhibitor of metalloproteinase
Relation:	Molecular Oncology
Appears in Collections:	[Department of Biotechnology] Journal Article

Files in This Item:

File	Size	Format
index.html	0Kb	HTML	509	View/Open

Loading...